Aβ-induced synaptic and neural network defects are closely related to tau, as reducing endogenous tau ameliorates Aβ-induced deficits in an AD mouse model mediated by postsynaptic molecular changes (Roberson et al., 2007). The gene discussed is MAPT; the disease is Alzheimer disease.